1. 1148. Activity of Posaconazole and Comparator Antifungal agents Tested Against Filamentous Fungi. (31st December 2020) Authors: Castanheira, Mariana; Carvalhaes, Cecilia G; Motyl, Mary; Han, Seongah; Campbell, Havilland Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1169. In Vitro Activity of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults Enrolled in a Clinical Trial. (31st December 2020) Authors: Castanheira, Mariana; Woosley, Leah; Motyl, Mary; Han, Seongah; Campbell, Havilland Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 127. Living on the Edge: The Impact of MIC Distributions on Empiric Antibiotic Selection. (4th December 2021) Authors: Bauer, Karri A; Hidayat, Levita K; Klinker, Kenneth; Motyl, Mary; Andrew DeRyke, C Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1273. Activity of Ceftolozane/Tazobactam and Comparators Against Enterobacterales and P. aeruginosa Isolates from Pediatric Patients—SMART United States 2017-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Harris, Kelly; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1273. Activity of Ceftolozane/Tazobactam and Comparators Against Enterobacterales and P. aeruginosa Isolates from Pediatric Patients—SMART United States 2017-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Harris, Kelly; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1274. Activity of Ceftolozane/Tazobactam, Imipenem/Relebactam, and Comparators Against Pseudomonas aeruginosa Isolates from Patients with Bloodstream and Other Infection Types—SMART United States/Canada 2018-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Harris, Kelly; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1274. Activity of Ceftolozane/Tazobactam, Imipenem/Relebactam, and Comparators Against Pseudomonas aeruginosa Isolates from Patients with Bloodstream and Other Infection Types—SMART United States/Canada 2018-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Harris, Kelly; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 1294. Activity of Ceftolozane/Tazobactam and Comparators against Resistant Pseudomonas aeruginosa Isolates from Patients with Respiratory Tract or Bloodstream Infections in ICU and non-ICU settings – SMART United States 2018-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Harris, Kelly; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 1295. Susceptibility to Ceftolozane/Tazobactam and Comparators Among Pseudomonas aeruginosa Isolates Collected from Patients in Hospitals in Latin America – SMART 2017-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Pavía, Jacquleine; Siddiqui, Fakhar; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 1295. Susceptibility to Ceftolozane/Tazobactam and Comparators Among Pseudomonas aeruginosa Isolates Collected from Patients in Hospitals in Latin America – SMART 2017-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Pavía, Jacquleine; Siddiqui, Fakhar; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗